CA952020A - Anticonvulsant compositions containing di-substituted isocyanuric acid compounds and their salts - Google Patents
Anticonvulsant compositions containing di-substituted isocyanuric acid compounds and their saltsInfo
- Publication number
- CA952020A CA952020A CA088,854A CA88854A CA952020A CA 952020 A CA952020 A CA 952020A CA 88854 A CA88854 A CA 88854A CA 952020 A CA952020 A CA 952020A
- Authority
- CA
- Canada
- Prior art keywords
- salts
- compositions containing
- acid compounds
- isocyanuric acid
- substituted isocyanuric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000001773 anti-convulsant effect Effects 0.000 title 1
- 239000001961 anticonvulsive agent Substances 0.000 title 1
- 229960003965 antiepileptics Drugs 0.000 title 1
- -1 di-substituted isocyanuric acid compounds Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/30—Only oxygen atoms
- C07D251/34—Cyanuric or isocyanuric esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85472369A | 1969-09-02 | 1969-09-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA952020A true CA952020A (en) | 1974-07-30 |
Family
ID=25319399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA088,854A Expired CA952020A (en) | 1969-09-02 | 1970-07-22 | Anticonvulsant compositions containing di-substituted isocyanuric acid compounds and their salts |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3689651A (fr) |
| BE (1) | BE754759A (fr) |
| CA (1) | CA952020A (fr) |
| DE (1) | DE2038685C3 (fr) |
| FR (1) | FR2068533B1 (fr) |
| GB (1) | GB1284019A (fr) |
| ZA (1) | ZA705175B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2413722C3 (de) * | 1974-03-21 | 1982-04-08 | Bayer Ag, 5090 Leverkusen | Neue 1-(4-Phenoxy-phenyl)-1,3,5-triazin-Derivate, ein Verfahren zu ihrer Herstellung sowie ihre Anwendung als Arzneimittel |
| CN107207448B (zh) | 2014-10-01 | 2020-12-29 | 医学科技研究公司 | 抗微生物化合物、其制备方法及包含该抗微生物化合物的制品 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3145142A (en) * | 1962-05-31 | 1964-08-18 | Du Pont | Anticonvulsant process and composition |
-
0
- BE BE754759D patent/BE754759A/fr unknown
-
1969
- 1969-09-02 US US854723A patent/US3689651A/en not_active Expired - Lifetime
-
1970
- 1970-07-22 CA CA088,854A patent/CA952020A/en not_active Expired
- 1970-07-27 ZA ZA705175*A patent/ZA705175B/xx unknown
- 1970-07-29 DE DE2038685A patent/DE2038685C3/de not_active Expired
- 1970-08-12 GB GB38919/70A patent/GB1284019A/en not_active Expired
- 1970-08-24 FR FR7030877A patent/FR2068533B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| US3689651A (en) | 1972-09-05 |
| DE2038685A1 (de) | 1971-04-08 |
| GB1284019A (en) | 1972-08-02 |
| DE2038685C3 (de) | 1974-08-01 |
| FR2068533B1 (fr) | 1974-02-01 |
| DE2038685B2 (de) | 1974-01-10 |
| BE754759A (fr) | 1971-02-12 |
| ZA705175B (en) | 1972-03-29 |
| FR2068533A1 (fr) | 1971-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA964193A (en) | Injectable compositions containing salts of l-tetramisole | |
| CA965623A (en) | Herbicidal compositions containing oxadiazolidinedione | |
| CA952020A (en) | Anticonvulsant compositions containing di-substituted isocyanuric acid compounds and their salts | |
| CA923425A (en) | Compositions containing garcinia acid | |
| CA821525A (en) | N-acetylcysteine containing composition | |
| IL35582A (en) | 2-chloroethylphosphonic acid amides | |
| MY7500154A (en) | 3-quinoline-carboxylic acid compounds process for their manufacture and compositions containing them | |
| AU1450470A (en) | Herbicides containing haloacrylic acid derivatives | |
| CA979900A (en) | Dialkyltin salts of substituted pyridine-1-oxides | |
| AU453959B2 (en) | Hydroxycitric acid derivatives containing compositions | |
| CA806098A (en) | Compositions containing quaternary ammonium salts | |
| CA979808A (en) | Pharmaceutical composition containing 4-hydroxynicotinic acid | |
| CA804624A (en) | Alkylsulphuric acid salts of tetradecylguanidine | |
| CA829329A (en) | Alkylsulphuric acid salts of substituted guanidines | |
| CA803520A (en) | Pharmaceutical compositions containing hydroxycinnamic acid derivatives | |
| AU2105370A (en) | Hydroxycitric acid derivatives containing compositions | |
| AU442673B2 (en) | Disproportionation of aliphatic compounds | |
| AU434879B2 (en) | Animal feed compositions containing chartreusin | |
| AU422685B2 (en) | 3-quinoline-carboxylic acid compounds, process for their manufacture and compositions containing them | |
| CA809216A (en) | Pamoic acid salts | |
| AU431086B2 (en) | Cycloheptenyl compounds and acid salts thereof | |
| CA823111A (en) | Liquid hydroxylammonium acid sulfate composition | |
| CA919089A (en) | Feed compositions containing sulfaguanidine | |
| CA823616A (en) | Compositions containing oxygen-releasing compounds | |
| CA829875A (en) | Pharmaceutical compositions containing 1-methyl-4-phenyl-4-piperidinol |